XTX Topco’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
Other funds holding KLRS
SL
XTX Topco's KLRS Position: Q3 2026 in Review
XTX Topco opened a new position in Kalaris Therapeutics (KLRS) in Q3 2026: 14,726 shares worth $42.6K. The stake represents ﹤0.01% of the portfolio and ranks #3562 among its holdings. This is a return to the name: XTX Topco previously reported a position in KLRS as recently as Q4 2025.
XTX Topco first reported a position in KLRS in Q2 2022 and has held it in 12 quarters since. The position peaked at $274K in Q4 2022. 54 funds tracked by Wall St. Rank hold KLRS as of Q3 2026.
- XTX Topco held 14,726 shares of Kalaris Therapeutics worth $42.6K as of Q3 2026.
- Kalaris Therapeutics was a new XTX Topco position in Q3 2026.
- Kalaris Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q3 2026, its #3562 holding.
- XTX Topco first reported a position in Kalaris Therapeutics in Q2 2022 and has held it in 12 quarters since.
- XTX Topco's Kalaris Therapeutics position peaked at $274K in Q4 2022.
- 54 funds tracked by Wall St. Rank held Kalaris Therapeutics as of Q3 2026.
Based on XTX Topco's 13F filing for Q3 2026, filed 16 Nov 2026.